Image

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

Investigating the Safety and Effects of an Investigational Medication in FAP-Positive Solid Tumors

Recruiting
18 years and older
All
Phase 1
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study investigates FAP-positive solid tumors. Participants must have cancer with high levels of fibroblast activation protein (FAP).

The study evaluates the safety, side effects, and effectiveness of the investigational medication. It also looks at how the medication enters the bloodstream, how it is broken down, and how long it stays in the body.

  • Who can participate: Adults with advanced or metastatic solid tumors expressing fibroblast activation protein (FAP) can participate if they have received prior specific cancer treatments and meet health criteria.
  • Study details: Participants will take part in activities to evaluate the investigational medication. Some may receive a placebo, which is an inactive substance that looks like the investigational medication but does not contain any medicine.
  • Study timelines: The study will last about 5 years.
Print
Study details
    Ovarian Neoplasms
    Breast Neoplasms
    Pancreatic Intraductal Neoplasms
    Colorectal Neoplasms
    Esophageal Neoplasms
    Stomach Neoplasms
    Cholangiocarcinoma

NCT07213791

Eli Lilly and Company

12 September 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.